128 related articles for article (PubMed ID: 15082040)
1. 175Yb labeled polyaminophosphonates as potential agents for bone pain palliation.
Mathew B; Chakraborty S; Das T; Sarma HD; Banerjee S; Samuel G; Venkatesh M; Pillai MR
Appl Radiat Isot; 2004 May; 60(5):635-42. PubMed ID: 15082040
[TBL] [Abstract][Full Text] [Related]
2. 175Yb-labeled hydroxyapatite: a potential agent for use in radiation synovectomy of small joints.
Chakraborty S; Das T; Banerjee S; Subramanian S; Sarma HD; Venkatesh M
Nucl Med Biol; 2006 May; 33(4):585-91. PubMed ID: 16720253
[TBL] [Abstract][Full Text] [Related]
3. 177Lu labelled polyaminophosphonates as potential agents for bone pain palliation.
Chakraborty S; Das T; Unni PR; Sarma HD; Samuel G; Banerjee S; Venkatesh M; Ramamoorthy N; Pillai MR
Nucl Med Commun; 2002 Jan; 23(1):67-74. PubMed ID: 11748440
[TBL] [Abstract][Full Text] [Related]
4. 177Lu-labeled cyclic polyaminophosphonates as potential agents for bone pain palliation.
Das T; Chakraborty S; Unni PR; Banerjee S; Samuel G; Sarma HD; Venkatesh M; Pillai MR
Appl Radiat Isot; 2002 Aug; 57(2):177-84. PubMed ID: 12150276
[TBL] [Abstract][Full Text] [Related]
5. Radiolabeling, stability studies, and pharmacokinetic evaluation of thulium-170-labeled acyclic and cyclic polyaminopolyphosphonic acids.
Vats K; Das T; Sarma HD; Banerjee S; Pillai MR
Cancer Biother Radiopharm; 2013 Dec; 28(10):737-45. PubMed ID: 23931111
[TBL] [Abstract][Full Text] [Related]
6. 177Lu-EDTMP: a potential therapeutic bone agent.
Ando A; Ando I; Tonami N; Kinuya S; Kazuma K; Kataiwa A; Nakagawa M; Fujita N
Nucl Med Commun; 1998 Jun; 19(6):587-91. PubMed ID: 10234664
[TBL] [Abstract][Full Text] [Related]
7. Comparative studies of 177Lu-EDTMP and 177Lu-DOTMP as potential agents for palliative radiotherapy of bone metastasis.
Chakraborty S; Das T; Sarma HD; Venkatesh M; Banerjee S
Appl Radiat Isot; 2008 Sep; 66(9):1196-205. PubMed ID: 18372188
[TBL] [Abstract][Full Text] [Related]
8. 177Lu-EDTMP: a viable bone pain palliative in skeletal metastasis.
Chakraborty S; Das T; Banerjee S; Balogh L; Chaudhari PR; Sarma HD; Polyák A; Máthé D; Venkatesh M; Janoki G; Pillai MR
Cancer Biother Radiopharm; 2008 Apr; 23(2):202-13. PubMed ID: 18454689
[TBL] [Abstract][Full Text] [Related]
9. 227Th-EDTMP: a potential therapeutic agent for bone metastasis.
Washiyama K; Amano R; Sasaki J; Kinuya S; Tonami N; Shiokawa Y; Mitsugashira T
Nucl Med Biol; 2004 Oct; 31(7):901-8. PubMed ID: 15464392
[TBL] [Abstract][Full Text] [Related]
10. Feasibility study for production of 175Yb: a promising therapeutic radionuclide.
Chakraborty S; Unni PR; Venkatesh M; Pillai MR
Appl Radiat Isot; 2002 Sep; 57(3):295-301. PubMed ID: 12201133
[TBL] [Abstract][Full Text] [Related]
11. Preparation and preliminary biological evaluation of a novel 109Pd labeled porphyrin derivative for possible use in targeted tumor therapy.
Chakraborty S; Das T; Banerjee S; Sarma HD; Venkatesh M
Q J Nucl Med Mol Imaging; 2007 Mar; 51(1):16-23. PubMed ID: 17372569
[TBL] [Abstract][Full Text] [Related]
12. Preparation of 166Ho-oxine-lipiodol and its preliminary bioevaluation for the potential application in therapy of liver cancer.
Das T; Chakraborty S; Sarma HD; Venkatesh M; Banerjee S
Nucl Med Commun; 2009 May; 30(5):362-7. PubMed ID: 19282794
[TBL] [Abstract][Full Text] [Related]
13. Studies on 177Lu-labeled methylene diphosphonate as potential bone-seeking radiopharmaceutical for bone pain palliation.
Abbasi IA
Nucl Med Biol; 2011 Apr; 38(3):417-25. PubMed ID: 21492790
[TBL] [Abstract][Full Text] [Related]
14. Formulation, preclinical evaluation, and preliminary clinical investigation of an in-house freeze-dried EDTMP kit suitable for the preparation of 177Lu-EDTMP.
Das T; Sarma HD; Shinto A; Kamaleshwaran KK; Banerjee S
Cancer Biother Radiopharm; 2014 Dec; 29(10):412-21. PubMed ID: 25409337
[TBL] [Abstract][Full Text] [Related]
15. Preparation and biological evaluation of 153Sm-DOTMP as a potential agent for bone pain palliation.
Chakraborty S; Das T; Banerjee S; Chaudhari PR; Sarma HD; Venkatesh M; Pillai MR
Nucl Med Commun; 2004 Dec; 25(12):1169-76. PubMed ID: 15640774
[TBL] [Abstract][Full Text] [Related]
16. (170)Tm-EDTMP: a potential cost-effective alternative to (89)SrCl(2) for bone pain palliation.
Das T; Chakraborty S; Sarma HD; Tandon P; Banerjee S; Venkatesh M; Pillai MR
Nucl Med Biol; 2009 Jul; 36(5):561-8. PubMed ID: 19520297
[TBL] [Abstract][Full Text] [Related]
17. Chemical and biological evaluation of 153Sm and 166Ho complexes of 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetrakis(methylphosphonic acid monoethylester) (H4 dotp OEt).
Försterová M; Jandurová Z; Marques F; Gano L; Lubal P; Vanek J; Hermann P; Santos I
J Inorg Biochem; 2008 Jul; 102(7):1531-40. PubMed ID: 18374985
[TBL] [Abstract][Full Text] [Related]
18. Feasibility study for production and quality control of Yb-175 as a byproduct of no carrier added Lu-177 preparation for radiolabeling of DOTMP.
Salek N; Shirvani Arani S; Bahrami Samani A; Vosoghi S; Mehrabi M
Australas Phys Eng Sci Med; 2018 Mar; 41(1):69-79. PubMed ID: 29260406
[TBL] [Abstract][Full Text] [Related]
19. Radiopharmaceutical therapy for palliation of bone pain from osseous metastases.
Pandit-Taskar N; Batraki M; Divgi CR
J Nucl Med; 2004 Aug; 45(8):1358-65. PubMed ID: 15299062
[TBL] [Abstract][Full Text] [Related]
20. (175)Yb-TTHMP as a good candidate for bone pain palliation and substitute of other radiopharmaceuticals.
Safarzadeh L
Indian J Nucl Med; 2014 Jul; 29(3):135-9. PubMed ID: 25210277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
